United Kingdom· GB-APID-30932511000001103
Kanuma 20mg/10ml concentrate for solution for infusion vials
A sebelipase alfa product containing sebelipase alfa, registered in United Kingdom by Alexion Pharma UK Ltd. The same ATC class is registered in 14 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Sebelipase alfa is registered in 14 of 19 countries.
Countries holding a registration under ATC A16AB14 (sebelipase alfa), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Sebelipase alfa · ATC A16AB14
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Sebelipase alfa
- Manufacturer
- Alexion Pharma UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- A16AB14
- ATC class
- Sebelipase alfa
- Defined daily dose
- 5 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin5391527742050
- gtin05391527742050
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sebelipase alfa in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumKanuma 2 mg/mlAlexion Europe
- CanadaKANUMAALEXION PHARMA GMBH
- SwitzerlandKanuma 2 mg/ml, Konzentrat zur Herstellung einer InfusionslösungAlexion Pharma GmbH
- CzechiaKANUMAAlexion Europe SAS, Levallois-Perret
- SpainKANUMA 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSIONAlexion Europe Sas
- FinlandKANUMAAlexion Europe SAS
- FranceKANUMA 2 mg/ml,solution à diluer pour perfusionALEXION EUROPE
- IrelandKANUMA 2 mg/ml concentrate for solution for infusionAlexion Europe SAS
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Kanuma
- Liechtenstein · Kanuma
- Norway · Kanuma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f3d50d38-3e9e-4cbc-9e45-a3e15fe38091 GET /v1/drugs/f3d50d38-3e9e-4cbc-9e45-a3e15fe38091?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "30932511000001103",
"desc": "Kanuma 20mg/10ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd)",
"form": "Solution for infusion",
"vpid": "30937411000001104",
"source": "dmd",
"vtm_id": "777503005",
"strength": "2 mg",
"substance": "Sebelipase alfa",
"ingredient": "Sebelipase alfa",
"supplier_code": "12506711000001104"
}See everything about sebelipase alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.